Literature DB >> 18226086

Treatment challenges in the management of complicated skin and soft-tissue infections.

B I Eisenstein1.   

Abstract

Complicated skin and soft-tissue infections (cSSTIs) are a significant clinical problem, partially owing to increasing resistance of infecting bacteria to current antibiotic therapies. Two case studies that illustrate complications that can arise when treating cSSTIs are outlined, and methods that can be used to address the problem and the final treatment outcome are detailed. Although these are specific examples, intolerance of and bacterial resistance to current antibacterial therapies are problems that are often seen in the clinical setting and must be addressed appropriately. The use of new antibiotic agents is one potential solution to these problems, and some of these agents are highlighted. Selecting the most appropriate therapy for an infection is often crucial for patient welfare. This article presents some potential approaches to the treatment of cSSTIs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18226086     DOI: 10.1111/j.1469-0691.2008.01922.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  7 in total

Review 1.  The diagnosis of infection in chronic leg ulcers: A narrative review on clinical practice.

Authors:  Ut T Bui; Kathleen Finlayson; Helen Edwards
Journal:  Int Wound J       Date:  2019-01-29       Impact factor: 3.315

2.  Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.

Authors:  Francis F Arhin; Deborah C Draghi; Chris M Pillar; Thomas R Parr; Gregory Moeck; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

3.  Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.

Authors:  Helio S Sader; Thomas R Fritsche; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

4.  Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid.

Authors:  Rodrigo E Mendes; Helio S Sader; Lalitagauri M Deshpande; Binh An Diep; Henry F Chambers; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2009-11-25       Impact factor: 5.948

5.  Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline.

Authors:  Wanda C Reygaert
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

6.  Analysis of Virulence Genes Among Methicillin Resistant Staphylococcus aureus (MRSA) Strains.

Authors:  Seyedeh Mahsan Hoseini Alfatemi; Mohammad Motamedifar; Nahal Hadi; Hadi Sedigh Ebrahim Saraie
Journal:  Jundishapur J Microbiol       Date:  2014-06-01       Impact factor: 0.747

Review 7.  Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia.

Authors:  Mbiye A Mpenge; Alasdair P MacGowan
Journal:  Ther Clin Risk Manag       Date:  2015-04-07       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.